Daré Bioscience, Inc.
DARE
$0.72
$0.011.11%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.57% | -108.08% | 59.53% | 11.30% | 8.26% |
| Total Depreciation and Amortization | 3.16% | 3.78% | 10.89% | 6.10% | 158.66% |
| Total Amortization of Deferred Charges | -- | -- | -209.33% | -- | -- |
| Total Other Non-Cash Items | 17.35% | 54.76% | -35.45% | -3.96% | 27.17% |
| Change in Net Operating Assets | -37.93% | -274.58% | 9.61% | 177.49% | -40.99% |
| Cash from Operations | -22.72% | -482.23% | 426.69% | 91.84% | 0.97% |
| Capital Expenditure | -- | -- | -18.26% | -213.89% | 197.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -18.26% | -213.89% | 197.52% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | 58.47% | -103.99% | 8.87% | -11.36% | -178.47% |
| Issuance of Common Stock | 75.66% | -92.56% | -93.20% | 3,846.11% | 8.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 314.77% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 91.14% | -- | -- | 200.00% |
| Cash from Financing | 232.94% | -268.71% | -97.73% | 42,680.37% | -117.76% |
| Foreign Exchange rate Adjustments | -95.06% | 273.15% | -472.46% | -46.51% | -1.53% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.67% | -478.44% | -90.93% | 440.70% | 1.36% |